Stockreport

Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis [Yahoo! Finance]

Tarsus Pharmaceuticals, Inc.  (TARS) 
PDF Demodex blepharitis impacts approximately 25 million eye care patients in the U.S. – or 1 out of every 12 adults Campaign will kick off with a Facebook LIVE event on [Read more]